UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

AIDS (London), 2009-07, Vol.23 (11), p.1359-1366

2009

Volltextzugriff (PDF)

Uses and complications of isotretinoin therapy

Journal of the American Academy of Dermatology, 2001-11, Vol.45 (5), p.S150-S157

2001

Volltextzugriff (PDF)

Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007–2011

The Lancet infectious diseases, 2013-09, Vol.13 (9), p.762-768

2013

Volltextzugriff (PDF)

Trastuzumab and Vinorelbine as First-Line Therapy for HER2-Overexpressing Metastatic Breast Cancer: Multicenter Phase II Trial With Clinical Outcomes, Analysis of Serum Tumor Markers as Predictive Factors, and Cardiac Surveillance Algorithm

Journal of clinical oncology, 2003-08, Vol.21 (15), p.2889-2895

2003

Volltextzugriff (PDF)

Comparison of patient reported quality of life and impact of treatment side effects experienced with a taxane-containing regimen and standard anthracycline based chemotherapy for early breast cancer: 6 year results from the UK TACT trial (CRUK/01/001)

European journal of cancer (1990), 2014-09, Vol.50 (14), p.2375-2389

2014

Volltextzugriff (PDF)

Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus : Results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) diabetic substudy

Circulation (New York, N.Y.), 1999-12, Vol.100 (25), p.2477-2484

1999

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis

Journal of the American Academy of Dermatology, 2002-12, Vol.47 (6), p.821-833

2002

Volltextzugriff (PDF)

UGT Genotype May Contribute to Adverse Events Following Medication With Mycophenolate Mofetil in Pediatric Kidney Transplant Recipients

Clinical pharmacology and therapeutics, 2009-05, Vol.85 (5), p.495-500

2009

Volltextzugriff (PDF)

UGT1A9, UGT2B7, and MRP2 genotypes can predict mycophenolic acid pharmacokinetic variability in pediatric kidney transplant recipients

Therapeutic drug monitoring, 2012-12, Vol.34 (6), p.671-679

2012

Volltextzugriff (PDF)

Phase I Study of Recombinant Human Endostatin in Patients With Advanced Solid Tumors

Journal of clinical oncology, 2002-09, Vol.20 (18), p.3792-3803

2002

Volltextzugriff (PDF)

A multicentre randomized controlled trial of epidural corticosteroid injections for sciatica: the WEST study

Rheumatology (Oxford, England), 2005-11, Vol.44 (11), p.1399-1406

2005

Volltextzugriff (PDF)

Tacrolimus (FK506) ointment for atopic dermatitis: A phase I study in adults and children

Journal of the American Academy of Dermatology, 1998, Vol.38 (1), p.69-76

1998

Volltextzugriff (PDF)

Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial

Neurology, 2001-10, Vol.57 (8), p.1428-1434

Enlimomab Acute Stroke Trial Investigators

2001

Volltextzugriff (PDF)

Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD

Neurology, 2008-08, Vol.71 (7), p.474-480

2008

Volltextzugriff (PDF)

A series of 5-(5,6)-dihydrouracil substituted 8-hydroxy-[1,6]naphthyridine-7-carboxylic acid 4-fluorobenzylamide inhibitors of HIV-1 integrase and viral replication in cells

Bioorganic & medicinal chemistry letters, 2005-10, Vol.15 (20), p.4550-4554

2005

Volltextzugriff (PDF)

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial

The Lancet (British edition), 2003-05, Vol.361 (9369), p.1597-1602

2003

Volltextzugriff (PDF)

Development of Biologic Markers of Response and Assessment of Antiangiogenic Activity in a Clinical Trial of Human Recombinant Endostatin

Journal of clinical oncology, 2002-09, Vol.20 (18), p.3804-3814

2002

Volltextzugriff (PDF)

Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker integrelin in elective coronary intervention

Circulation (New York, N.Y.), 1995-04, Vol.91 (8), p.2151-2157

1995

Volltextzugriff (PDF)

Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer

American journal of clinical oncology, 2001-04, Vol.24 (2), p.107-112

2001

Volltextzugriff (PDF)

AIDS-related and non-AIDS-related mortality in the Asia-Pacific region in the era of combination antiretroviral treatment

AIDS (London), 2009-11, Vol.23 (17), p.2323-2336

2009

Volltextzugriff (PDF)

Does Health-Related Quality of Life Improve for Advanced Pancreatic Cancer Patients Who Respond to Gemcitabine? Analysis of a Randomized Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

Journal of pain and symptom management, 2012-02, Vol.43 (2), p.205-217

2012

Volltextzugriff (PDF)

Hospitalizations in a cohort of HIV patients in Australia, 1999―2007

AIDS (London), 2010-06, Vol.24 (9), p.1329-1339

2010

Volltextzugriff (PDF)

Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: The integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trial

Journal of the American College of Cardiology, 2002-02, Vol.39 (3), p.377-386

2002

Volltextzugriff (PDF)

Combined accelerated tissue-plasminogen activator and Platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute Myocardial Infarction : Results of a randomized, placebo-controlled, dose-ranging trial

Circulation (New York, N.Y.), 1997-02, Vol.95 (4), p.846-854

1997

Volltextzugriff (PDF)

Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study)

Circulation (New York, N.Y.), 1999-08, Vol.100 (8), p.799-806

1999

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

ThemaPharmacology. Drug Treatments

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(83)

Sprache

Englisch
(83)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(83)
Medical Sciences
(83)
Life Sciences & Biomedicine
(64)
Science & Technology
(64)
Humans
(50)
Male
(40)
Female
(38)
Adult
(36)
Middle Aged
(32)
Dermatology
(20)
Aged
(19)
Pharmacology & Pharmacy
(18)
Skin, Nail, Hair, Dermoskeleton
(16)
Double-Blind Method
(14)
Adolescent
(13)
Psoriasis - Drug Therapy
(13)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(12)
Dose-Response Relationship, Drug
(12)
Treatment Outcome
(12)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

Uses and complications of isotretinoin therapy

Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007–2011

Trastuzumab and Vinorelbine as First-Line Therapy for HER2-Overexpressing Metastatic Breast Cancer: Multicenter Phase II Trial With Clinical Outcomes, Analysis of Serum Tumor Markers as Predictive Factors, and Cardiac Surveillance Algorithm

Comparison of patient reported quality of life and impact of treatment side effects experienced with a taxane-containing regimen and standard anthracycline based chemotherapy for early breast cancer: 6 year results from the UK TACT trial (CRUK/01/001)

Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus : Results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) diabetic substudy

A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis

UGT Genotype May Contribute to Adverse Events Following Medication With Mycophenolate Mofetil in Pediatric Kidney Transplant Recipients

UGT1A9, UGT2B7, and MRP2 genotypes can predict mycophenolic acid pharmacokinetic variability in pediatric kidney transplant recipients

Phase I Study of Recombinant Human Endostatin in Patients With Advanced Solid Tumors

A multicentre randomized controlled trial of epidural corticosteroid injections for sciatica: the WEST study

Tacrolimus (FK506) ointment for atopic dermatitis: A phase I study in adults and children

Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial

Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD

A series of 5-(5,6)-dihydrouracil substituted 8-hydroxy-[1,6]naphthyridine-7-carboxylic acid 4-fluorobenzylamide inhibitors of HIV-1 integrase and viral replication in cells

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial

Development of Biologic Markers of Response and Assessment of Antiangiogenic Activity in a Clinical Trial of Human Recombinant Endostatin

Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker integrelin in elective coronary intervention

Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer

AIDS-related and non-AIDS-related mortality in the Asia-Pacific region in the era of combination antiretroviral treatment

Does Health-Related Quality of Life Improve for Advanced Pancreatic Cancer Patients Who Respond to Gemcitabine? Analysis of a Randomized Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

Hospitalizations in a cohort of HIV patients in Australia, 1999―2007

Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: The integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trial

Combined accelerated tissue-plasminogen activator and Platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute Myocardial Infarction : Results of a randomized, placebo-controlled, dose-ranging trial

Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study)

Aktive Filter

Suchergebnisse filtern